Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study

Digestive and Liver Disease

Volumn 43, Issue 10, 2011, Pages 828-833

  Le Roux, Catherine ^a   Lombard Bohas, Catherine ^b   Delmas, Christelle ^a   Dominguez Tinajero, Sophie ^c   Ruszniewski, Philippe ^d   Samalin, Emmanuelle ^e   Raoul, Jean Luc ^f   Renard, Pascal ^g   Baudin, Eric ^h   Robaskiewicz, Michel ⁱ   Mitry, Emmanuel ^j   Cadiot, Guillaume ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d BEAUJON HOSPITAL   (France)

^e CENTRE VAL D AURELLE   (France)

^f CENTRE EUGÈNE MARQUIS   (France)

^g Polyclinique de Courlancy   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ SERVICE DE RHUMATOLOGIE   (France)

^j HÔPITAL AMBROISE PARÉ   (France)

more..

Author keywords

Emergency surgery; Ileum; Liver metastases; Multiple tumours; Neuroendocrine tumours; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DATA BASE; DISEASE FREE SURVIVAL; EMERGENCY SURGERY; FEMALE; FOLLOW UP; HUMAN; ILEAL NEUROENDOCRINE TUMOR; ILEUM RESECTION; ILEUM TUMOR; LIVER INJURY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CANCER; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL PATIENT; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; EMERGENCIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; ILEAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MESENTERY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMORS; ODDS RATIO; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TUMOR BURDEN;

EID: 80052487981     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.04.021     Document Type: Article

References (37)

1. Moertel C.G. Karnofsky Memorial Lecture. An odyssey in the land of small tumors. J Clin Oncol 1987, 5:1502-1522.
2. Yao J.C., Hassan M., Phan A., et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008, 26:3063-3071.
3. Modlin I.M., Champaneria M.C., Chan A.K., et al. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 2007, 102:1464-1473.
4. Burke A., Thomas R., Elsayed A., et al. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997, 79:1086-1093.
5. Akerström G., Hellman P., Hessman O., et al. Management of midgut carcinoids. J Surg Oncol 2005, 89:161-169.
6. Modlin I.M., Kidd M., Latich I., et al. Current status of gastrointestinal carcinoids. Gastroenterology 2005, 128:1717-1751.
7. Sjöblom S.M. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scand J Gastroenterol 1988, 23:779-787.
8. Thompson G.B., van Heerden J.A., Martin J.K., et al. Carcinoid tumors of the gastrointestinal tract: presentation, management and prognosis. Surgery 1985, 98:1054-1063.
9. Bax N.D., Woods H.F., Batchelor A., et al. Clinical manifestations of carcinoid disease. World J Surg 1996, 20:142-146.
10. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005, 103:1587-1595.
11. Van Gompel J.J., Sippel R.S., Warner T.F., et al. Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg 2004, 28:387-392.
12. Sutton R., Doran E.H., Williams E.M.I., et al. Surgery for midgut carcinoid. Endocr-Relat Cancer 2003, 10:469-481.
13. Makridis C., Ekbom A., Bring J., et al. Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery 1997, 122:1075-1082.
14. Modlin I.M., Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997, 79:813-829.
15. Shebani K.O., Souba W.W., Finkelstein D.M., et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999, 229:815-821.
16. Söreide J.A., van Heerden J.A., Thompson G.B., et al. Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients. World J Surg 2000, 24:1431-1436.
17. Janson E.T., Holmberg L., Stridsberg M., et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 1997, 8:685-690.
18. Strosberg J., Gardner N., Kvols L. Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut. Neuroendocrinology 2009, 89:471-476.
19. Zar N., Garmo H., Holmberg L., et al. Long-term survival of patients with small intestinal carcinoid tumors. World J Surg 2004, 28:1163-1168.
20. Yantiss R.K., Odze R.D., Farraye F.A., et al. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathological review of 68 cases. Am J Surg Pathol 2003, 27:811-817.
21. Tomassetti P., Campana D., Piscitelli L., et al. Endocrine tumors of the ileum: factors correlated with survival. Neuroendocrinology 2006, 83:380-386.
22. Jann H., Roll S., Couvelard A., et al. Neuroendocrine tumors of midgut and hindgut origin: Tumor-Node-Metastasis classification determines clinical outcome. Cancer 2011, 10.1002/cncr.25855.
23. Klöppel G., Couvelard A., Perren A., et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009, 90:162-166.
24. Histological typing of endocrine tumors. WHO Classification of Endocrine Tumors 2000, Springer-Verlag, New York. E. Solcia, G. Klöppel, L.H. Sobin (Eds.).
25. Rindi G., Klöppel G., Couvelard A., et al. TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007, 451:757-762.
26. Öhrvall U., Eriksson B., Juhlin C., et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 2000, 24:1402-1408.
27. McDermott E.W., Guduric B., Brennan M.F. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 1994, 81:1007-1009.
28. Quaedvlieg P.F., Visser O., Lamers C.B. Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2391 patients. Ann Oncol 2001, 12:1295-1300.
29. Hellman P., Lundström T., Ohrvall U., et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 2002, 26:991-997.
30. Yantiss R.K., Odze R.D., Farraye F.A., et al. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol 2003, 27:811-817.
31. Zeitels J., Naunheim K., Kaplan E.L., et al. Carcinoid tumors: a 37-year experience. Arch Surg 1982, 117:732-737.
32. Capella C., Arnold R., Klimstra D.S., et al. Neuroendocrine neoplasms of the small intestine. WHO classification of tumours of the digestive system 2010, 102-107. International Agency for Research on Cancer, Lyon. F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise (Eds.).
33. Klimstra D.S., Arnold R., Capella C., et al. Neuroendocrine neoplasms of the pancreas. WHO classification of tumours of the digestive system 2010, 322-326. International Agency for Research on Cancer, Lyon. F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise (Eds.).
34. Dromain C., de Baere T., Lumbroso J., et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 2005, 23:70-78.
35. Dromain C., Baudin E. Imaging strategy for staging and follow-up of endocrine tumors. Bull Cancer 2006, 93:1183-1189.
36. Welin S., Stridsberg M., Cunningham J., et al. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors. Neuroendocrinology 2009, 89:302-307.
37. Arnold R., Chen Y.J., Costa F., et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: follow-up and documentation. Neuroendocrinology 2009, 90:227-233.